Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.

Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.

http://www.wikidata.org/entity/Q35051878

about

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.Reverse of non-small cell lung cancer drug resistance induced by cancer associated fibroblasts via a paracrine pathway.Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.

P2860

Q35739745-A461540E-E2A7-44CE-80AF-6C3187215492 Q36105571-A22F12B8-843F-4E25-A6C0-E4CFC31CEF88 Q38328376-DE0B5442-0FCC-408D-B888-FFADC4865636 Q41491991-C9D47B46-278A-4C08-A08F-82B6D9D9C405 Q48518636-8CAF6C84-6510-4103-8395-0CF23C16F8E7 Q49831684-07295D49-0F1E-4B90-9A5D-B94B6C24DD67 Q51531167-3280ECD0-D267-423A-88DF-80411EEBD508

P2860

Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.

http://www.wikidata.org/entity/Q35051878

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Immunophenotypic features of m ...... lung squamous cell carcinoma.

@ast

Immunophenotypic features of m ...... lung squamous cell carcinoma.

@en

type

label

Immunophenotypic features of m ...... lung squamous cell carcinoma.

@ast

Immunophenotypic features of m ...... lung squamous cell carcinoma.

@en

prefLabel

Immunophenotypic features of m ...... lung squamous cell carcinoma.

@ast

Immunophenotypic features of m ...... lung squamous cell carcinoma.

@en

P1433

Q35051878-08EF2068-C9E0-4F80-8F1D-EB6EF5343C55

P1476

Q35051878-84606B29-8509-4237-91C0-968E35116ACD

P2093

Q35051878-00D6FC2E-1096-426F-BF77-281E44E29905

Q35051878-3DC8EEB4-A529-49DC-A6BF-C82DF894918D

Q35051878-3E359F0E-3306-47EB-868A-EE86A11DA90A

Q35051878-63DDF41B-6370-4CC5-87B3-490E23F740FA

Q35051878-674B95F7-ADE2-45A9-AEF8-4A038F3AFB07

Q35051878-6DD75E73-136E-4993-BB9D-A3F6EDA96F1F

Q35051878-7AE017AC-28E2-4FD4-BA1D-79286DD46A70

Q35051878-97D80A07-BC6F-4EE2-8F61-732BA133DE0D

Q35051878-AF4B0B4F-474C-447F-99DB-B1E7D5FCEE2B

Q35051878-D3DA98D0-BC90-4E3A-A7CE-7331BBC51F8D

P2860

Q35051878-087041D6-5DE4-43BB-AB32-1AA6C7775FA3

Q35051878-15F9234E-CED5-46FD-A17D-B8891CF3B603

Q35051878-1B1DF1C2-2DFD-456B-9D51-0C34128405FF

Q35051878-1B36466B-234A-4CCE-8DD7-EDC89C24AC13

Q35051878-28BFCE13-AA25-4506-A5C0-46C95D35ED08

Q35051878-32F30ECB-FFCC-4DCF-9729-920D5C1E7BD4

Q35051878-36580C27-4455-45B6-B22F-5C66BBFAA297

Q35051878-3E3D7F0F-DBD9-478E-AB37-2E41E13C0D84

Q35051878-426A8640-B096-497A-8264-9B7240C4CF83

Q35051878-4AB9A68E-5B9D-4869-A90F-69DE708B243C

P304

Q35051878-EE381800-7402-4E7D-8104-196B686D60EA

P31

Q35051878-B8BF9FD6-D459-495C-9DCB-A627E23C296A

P356

Q35051878-0ABE80A9-37B2-465F-8666-A67148D96D74

P433

Q35051878-EFEB0E6D-8174-4123-BE2B-1631CACE35B2

P478

Q35051878-4C47B8CD-1B0A-406A-8E66-109F01013029

P50

Q35051878-D133B2F0-6EBD-4E90-BC76-C9A3D865C891

P577

Q35051878-50105EC8-2FCF-4E53-B792-6669CDBCAB55

P5875

Q35051878-091EE62D-E746-4BC7-8784-CF29B8F848E3

P698

Q35051878-10DCC56A-E343-48BA-846D-5D4CD48A4C0B

P932

Q35051878-A680DD2D-A171-4219-A9F2-7A186A8EFB6C

P356

P1433

P1476

Immunophenotypic features of m ...... 2 lung squamous cell carcinoma

@en

P2093

Atsushi Ochiai

http://www.w3.org/2001/XMLSchema#string

Genichiro Ishii

http://www.w3.org/2001/XMLSchema#string

Haruhiko Kondo

http://www.w3.org/2001/XMLSchema#string

Kanji Nagai

http://www.w3.org/2001/XMLSchema#string

Keiju Aokage

http://www.w3.org/2001/XMLSchema#string

Rie Matsuwaki

http://www.w3.org/2001/XMLSchema#string

Satoshi Fujii

http://www.w3.org/2001/XMLSchema#string

Shinya Neri

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Goya

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Hishida

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.

Correlation of CD44v6 expression with ovarian cancer progression and recurrence.

Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival

Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer

Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.

Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase

Squamous-cell carcinoma of the lungs: is it really so different?

Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells.

Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.

P304

905-911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12434

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262231842

http://www.w3.org/2001/XMLSchema#string

P698

24814677

http://www.w3.org/2001/XMLSchema#string

P932

4317916

http://www.w3.org/2001/XMLSchema#string